Clinical trials
Glucose Metabolism Disorders trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Ultragenyx Pharmaceutical Inc | 2 |
| Aichi Gakuin University | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Pfizer | 1 |
| Takeda | 1 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 11 |
| Diabetes Mellitus | 8 |
| Diabetes Mellitus, Type 2 | 8 |
| Metabolic Diseases | 8 |
| Endocrine System Diseases | 6 |
| Glycogen Storage Disease Type I | 2 |
| Acute Coronary Syndrome | 1 |
| Body Weight | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Complications | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.